Enzyme Immunoassays for Detection of Malarial Antigens in Human Plasmas by Plasmodium falciparum Monoclonal Antibodies

Michel Dubarry Laboratoire d'Immunochimie, Institut National de Transfusion Sanguine, INSERM U 313, Faculté de Médecine, Paris, France

Search for other papers by Michel Dubarry in
Current site
Google Scholar
PubMed
Close
,
Michèle Luilier Laboratoire d'Immunochimie, Institut National de Transfusion Sanguine, INSERM U 313, Faculté de Médecine, Paris, France

Search for other papers by Michèle Luilier in
Current site
Google Scholar
PubMed
Close
,
Nicole Malot Laboratoire d'Immunochimie, Institut National de Transfusion Sanguine, INSERM U 313, Faculté de Médecine, Paris, France

Search for other papers by Nicole Malot in
Current site
Google Scholar
PubMed
Close
,
Pierre Bayard Laboratoire d'Immunochimie, Institut National de Transfusion Sanguine, INSERM U 313, Faculté de Médecine, Paris, France

Search for other papers by Pierre Bayard in
Current site
Google Scholar
PubMed
Close
,
Patrick Lambin Laboratoire d'Immunochimie, Institut National de Transfusion Sanguine, INSERM U 313, Faculté de Médecine, Paris, France

Search for other papers by Patrick Lambin in
Current site
Google Scholar
PubMed
Close
,
Odette Prou Laboratoire d'Immunochimie, Institut National de Transfusion Sanguine, INSERM U 313, Faculté de Médecine, Paris, France

Search for other papers by Odette Prou in
Current site
Google Scholar
PubMed
Close
, and
Loīc Monjour Laboratoire d'Immunochimie, Institut National de Transfusion Sanguine, INSERM U 313, Faculté de Médecine, Paris, France

Search for other papers by Loīc Monjour in
Current site
Google Scholar
PubMed
Close
Restricted access

The screening of blood donors for the detection of dangerous disease carriers is a mandatory requirement for blood transfusion centers. Enzyme immunoassay (EIA) is a suitable method for the examination of large populations. We describe a sandwich EIA allowing the detection of soluble malarial antigens in plasma using 11 mouse monoclonal antibodies. Among the 121 combinations tested, 2 were selected for their sensitivity and specificity. Both were applied to plasmas of (a) acute patients, (b) people living in malarious areas, (c) blood donors at risk (travelers), and (d) sedentary blood donors without risk. With 1 of the 2 combinations, the percentage of positive answers was 68.4% (n = 38) for a, 62.6% (n = 206) for b, 4.5% (n = 398) for c, and 0.8% (n = 485) for d; with the other combination, the percentage of positive answers was 68.4% for a, 46.1% for b, 1.5% for c, and 0% for d. Using 2 combinations simultaneously, the positive results were 94.7% for a, 70.4% for b, 5% for c, and 0.8% for d. The 2 assays are complementary and the pair can be used for maximum Plasmodium falciparum antigen recognition in prospective donors.

Author Notes

Save